{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:45:34Z","timestamp":1782744334888,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100031991","name":"Horus Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100031991","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40123-026-01415-z","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:30:41Z","timestamp":1780669841000},"page":"2379-2394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding Patient Preferences and Their Impact on Adherence to Glaucoma Therapy: A Multicenter Cross-Sectional Study"],"prefix":"10.1007","volume":"15","author":[{"given":"Tom\u00e1s","family":"Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Labay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Duch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Arciniegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Vendrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Djavanmardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuris Nuria","family":"Gabarr\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiara","family":"Rela\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alegria","family":"Amram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mill\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"10414","key":"1415_CR1","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","volume":"402","author":"H Jayaram","year":"2023","unstructured":"Jayaram H, Kolko M, Friedman DS, Gazzard G. Glaucoma: now and beyond. Lancet Lond Engl. 2023;402(10414):1788\u2013801.","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"1415_CR2","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.mayocpiqo.2022.09.007","volume":"6","author":"IV Wagner","year":"2022","unstructured":"Wagner IV, Stewart MW, Dorairaj SK. Updates on the diagnosis and management of glaucoma. Mayo Clin Proc Innov Qual Outcomes. 2022;6(6):618\u201335.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"1415_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000334776","volume":"50","author":"PT Khaw","year":"2012","unstructured":"Khaw PT, Chiang M, Shah P, Sii F, Lockwood A, Khalili A. Enhanced trabeculectomy: the Moorfields safer surgery system. Dev Ophthalmol. 2012;50:1\u201328.","journal-title":"Dev Ophthalmol"},{"issue":"1","key":"1415_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12886-025-04183-9","volume":"25","author":"R Verma-Fuehring","year":"2025","unstructured":"Verma-Fuehring R, Matlach J, Klink T, Hillenkamp J, Grehn F. Long-term outcomes of trabeculectomy versus canaloplasty in open-angle glaucoma\u2014An 11-year follow-up of the TVC study cohort. BMC Ophthalmol. 2025;25(1):340.","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"1415_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/APO.0000000000000023","volume":"2","author":"SE Skalicky","year":"2013","unstructured":"Skalicky SE, Goldberg I. Adherence and persistence: the challenges for glaucoma medical therapy. Asia-Pac J Ophthalmol. 2013;2(6):356\u201361.","journal-title":"Asia-Pac J Ophthalmol"},{"issue":"6","key":"1415_CR6","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1007\/s40123-023-00797-8","volume":"12","author":"SG Moore","year":"2023","unstructured":"Moore SG, Richter G, Modjtahedi BS. Factors affecting glaucoma medication adherence and interventions to improve adherence: a narrative review. Ophthalmol Ther. 2023;12(6):2863\u201380.","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"1415_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","volume":"42","author":"MR DiMatteo","year":"2004","unstructured":"DiMatteo MR. Variations in patients\u2019 adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200\u20139.","journal-title":"Med Care"},{"issue":"2","key":"1415_CR8","first-page":"190","volume":"17","author":"JC Tsai","year":"2006","unstructured":"Tsai JC. Medication adherence in glaucoma: approaches for optimizing patient compliance. Curr Opin Ophthalmol. 2006;17(2):190\u20135.","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"1415_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/10807680260362687","volume":"18","author":"SA Taylor","year":"2002","unstructured":"Taylor SA, Galbraith SM, Mills RP. Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther. 2002;18(5):401\u20139.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"1415_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/eye.2011.279","volume":"26","author":"P Leighton","year":"2012","unstructured":"Leighton P, Lonsdale AJ, Tildsley J, King AJ. The willingness of patients presenting with advanced glaucoma to participate in a trial comparing primary medical vs primary surgical treatment. Eye Lond. 2012;26(2):300\u20136.","journal-title":"Eye Lond"},{"key":"1415_CR11","doi-asserted-by":"crossref","unstructured":"Lawlor M, Goldberg I. Chapter 24 - Section summary: recommendations in treatment-na\u00efve open-angle glaucoma, treatment escalation protocols, and patient-specific considerations. In: Gillmann K, Mansouri K, editors. The Science of Glaucoma Management [Internet]. Academic Press; 2023 [cited 2025 Oct 10]. p. 247\u20139. https:\/\/www.sciencedirect.com\/science\/article\/pii\/B978032388442600011X.","DOI":"10.1016\/B978-0-323-88442-6.00011-X"},{"issue":"1","key":"1415_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4103\/0301-4738.44495","volume":"57","author":"BL Sleath","year":"2009","unstructured":"Sleath BL, Krishnadas R, Cho M, Robin AL, Mehta R, Covert D, et\u00a0al. Patient-reported barriers to glaucoma medication access, use, and adherence in southern India. Indian J Ophthalmol. 2009;57(1):63\u20138.","journal-title":"Indian J Ophthalmol"},{"key":"1415_CR13","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.2147\/OPTH.S88891","volume":"9","author":"R Altafini","year":"2015","unstructured":"Altafini R, Scherzer ML, Hubatsch DA, Frezzotti P. Brinzolamide 1%\/timolol versus dorzolamide 2%\/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study. Clin Ophthalmol Auckl N Z. 2015;9:2263\u201370.","journal-title":"Clin Ophthalmol Auckl N Z"},{"issue":"1","key":"1415_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1442-9071.2012.02823.x","volume":"41","author":"NM Kerr","year":"2013","unstructured":"Kerr NM, Patel HY, Chew SS, Ali NQ, Eady EK, Danesh-Meyer HV. Patient satisfaction with topical ocular hypotensives. Clin Exp Ophthalmol. 2013;41(1):27\u201335.","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"1415_CR15","first-page":"540","volume":"121","author":"HD Jampel","year":"2003","unstructured":"Jampel HD, Schwartz GF, Robin AL, Abrams DA, Johnson E, Miller RB. Patient preferences for eye drop characteristics: a willingness-to-pay analysis. Arch Ophthalmol Chic Ill 1960. 2003;121(4):540\u20136.","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"1415_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2147\/OPTH.S295821","volume":"15","author":"C Erb","year":"2021","unstructured":"Erb C, Stalmans I, Iliev M, Mu\u00f1oz-Negrete FJ. Real-world study on patient satisfaction and tolerability after switching to preservative-free latanoprost. Clin Ophthalmol Auckl N Z. 2021;15:931\u20138.","journal-title":"Clin Ophthalmol Auckl N Z"},{"key":"1415_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2147\/OPTH.S126042","volume":"11","author":"FJ Munoz-Negrete","year":"2017","unstructured":"Munoz-Negrete FJ, Lemij H, Erb C. Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction. Clin Ophthalmol. 2017;11:557\u201366.","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"1415_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/sj.eye.6701932","volume":"20","author":"DG Day","year":"2006","unstructured":"Day DG, Sharpe ED, Atkinson MJ, Stewart JA, Stewart WC. The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye. 2006;20(5):583\u201390.","journal-title":"Eye"},{"issue":"10\u201312","key":"1415_CR19","first-page":"347","volume":"110","author":"M Kowal","year":"2008","unstructured":"Kowal M, Choragiewicz T, Mietlicka K, Wyszy\u0144ska A, Zarnowski T. Obstacles to medication compliance for patients with glaucoma. Klin Oczna. 2008;110(10\u201312):347\u201351.","journal-title":"Klin Oczna"},{"issue":"12","key":"1415_CR20","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/IJG.0000000000002487","volume":"33","author":"O Olawoye","year":"2024","unstructured":"Olawoye O, Sarimiye T, Washaya J, Gessesse GW, Balo K, Agre J, et\u00a0al. Patients\u2019 acceptance of glaucoma therapy in sub-Saharan Africa. J Glaucoma. 2024;33(12):951\u20136.","journal-title":"J Glaucoma"},{"issue":"5","key":"1415_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-081998","volume":"14","author":"A Safitri","year":"2024","unstructured":"Safitri A, Konstantakopoulou E, Gazzard G, Hu K. Priorities for health outcomes in glaucoma in an ethnically diverse UK cohort: an observational study. BMJ Open. 2024;14(5):e081998.","journal-title":"BMJ Open"},{"issue":"3","key":"1415_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5771","volume":"33","author":"GS Motta","year":"2024","unstructured":"Motta GS, da Costa Andrade J, Kasahara N. How glaucoma patients balance between the advantages and disadvantages of acceptance to the recommended treatment regimen in real-life: perspectives from a middle-income country. Pharmacoepidemiol Drug Saf. 2024;33(3):e5771.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"16","key":"1415_CR23","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1038\/s41433-023-02532-w","volume":"37","author":"A Safitri","year":"2023","unstructured":"Safitri A, Konstantakopoulou E, Hu K, Gazzard G. Treatment expectations in glaucoma: what matters most to patients? Eye. 2023;37(16):3446\u201354.","journal-title":"Eye"},{"issue":"12","key":"1415_CR24","first-page":"1850","volume":"103","author":"BB Kulkarni","year":"2019","unstructured":"Kulkarni BB, Leighton P, King AJ. Exploring patients\u2019 expectations and preferences of glaucoma surgery outcomes to facilitate healthcare delivery and inform future glaucoma research. Br J Ophthalmol. 2019;103(12):1850\u20135.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"1415_CR25","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1167\/iovs.07-0559","volume":"49","author":"PA Aspinall","year":"2008","unstructured":"Aspinall PA, Johnson ZK, Azuara-Blanco A, Montarzino A, Brice R, Vickers A. Evaluation of quality of life and priorities of patients with glaucoma. Invest Ophthalmol Vis Sci. 2008;49(5):1907\u201315.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"1415_CR26","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1167\/iovs.05-1244","volume":"47","author":"JS Bhargava","year":"2006","unstructured":"Bhargava JS, Patel B, Foss AJE, Avery AJ, King AJ. Views of glaucoma patients on aspects of their treatment: an assessment of patient preference by conjoint analysis. Invest Ophthalmol Vis Sci. 2006;47(7):2885\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1415_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5935\/0034-7280.20150048","volume":"74","author":"AAP Vieira","year":"2015","unstructured":"Vieira AAP, Guedes RAP, Vieira RCPA, Guedes VMP. Patient\u2019s perception on glaucoma and different types of treatment (medical versus surgical treatment). Rev Bras Oftalmol. 2015;74(4):235\u201340.","journal-title":"Rev Bras Oftalmol."},{"issue":"1","key":"1415_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/09286586.2022.2029500","volume":"30","author":"Y Chen","year":"2023","unstructured":"Chen Y, Lohfeld L, Song D, Pak C, Gong X, Zhou W, et\u00a0al. Facilitators and barriers to using selective laser trabeculoplasty (SLT) as first-line treatment for glaucoma: physician and patient views gathered during an exploratory descriptive qualitative study. Ophthalmic Epidemiol. 2023;30(1):74\u201381.","journal-title":"Ophthalmic Epidemiol"},{"issue":"8","key":"1415_CR29","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/OPX.0000000000000009","volume":"90","author":"LE Dreer","year":"2013","unstructured":"Dreer LE, Girkin CA, Campbell L, Wood A, Gao L, Owsley C. Glaucoma medication adherence among African Americans: program development. Optom Vis Sci. 2013;90(8):883\u201397.","journal-title":"Optom Vis Sci"},{"issue":"11","key":"1415_CR30","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1007\/s12325-025-03353-x","volume":"42","author":"P Bastelica","year":"2025","unstructured":"Bastelica P, Labbe A, Sahyoun M, Baudouin C, Lamirel C, Poli M, et\u00a0al. Patient preferences and understanding of glaucoma treatment: a nationwide survey by the French Glaucoma Society. Adv Ther. 2025;42(11):5547\u201363.","journal-title":"Adv Ther"},{"issue":"3","key":"1415_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/jop.2009.0111","volume":"26","author":"M Parkkari","year":"2010","unstructured":"Parkkari M, Latvala T, Ropo A. Handling test of eye drop dispenser\u2014Comparison of unit-dose pipettes with conventional eye drop bottles. J Ocul Pharmacol Ther. 2010;26(3):273\u20136.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1415_CR32","unstructured":"Comparative usability study of multidose preservative-free eye drop devices [Internet]. ONdrugDelivery. 2024 [cited 2025 Nov 3]. https:\/\/ondrugdelivery.com\/comparative-usability-study-of-multidose-preservative-free-eye-drop-devices\/."},{"issue":"5","key":"1415_CR33","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jcjo.2021.06.005","volume":"57","author":"KA Rahemtulla","year":"2022","unstructured":"Rahemtulla KA, Cheema MK, Nickonchuk T, Guirguis M, Al Hamarneh YN, Damji KF. Quantifying the cost of single-use minims and multidose bottles for eye drops in routine ophthalmic practice: a multicentre study. Can J Ophthalmol. 2022;57(5):312\u20138.","journal-title":"Can J Ophthalmol"},{"issue":"17","key":"1415_CR34","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.2147\/OPTH.S435467","volume":"30","author":"KL Guti\u00e9rrez","year":"2023","unstructured":"Guti\u00e9rrez KL, Thomas S, Martin JL, Dahlmann-Noor A. Usability of an eye drop delivery aid for single-dose instillation: results from a market research study. Clin Ophthalmol. 2023;30(17):3675\u201384.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"1415_CR35","first-page":"40","volume":"3","author":"IS Ivanov","year":"2024","unstructured":"Ivanov IS, Akhmedova DA, Koroleva YA, Shatalov DO. Sterility of ophthalmic solutions as a factor in the evolution of primary packaging for eye drops: a literature review. Sci Pharm. 2024;3(1):40\u201350.","journal-title":"Sci Pharm"},{"issue":"4","key":"1415_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s40135-021-00273-1","volume":"9","author":"MJ Gale","year":"2021","unstructured":"Gale MJ, Kinast RM, Sanchez FG, Mansberger SL. Adherence with glaucoma medications: barriers to success and prospects for improvement. Curr Ophthalmol Rep. 2021;9(4):184\u20139.","journal-title":"Curr Ophthalmol Rep"},{"issue":"4","key":"1415_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3129\/i08-076","volume":"43","author":"R Kholdebarin","year":"2008","unstructured":"Kholdebarin R, Campbell RJ, Jin YP, Buys YM. Multicenter study of compliance and drop administration in glaucoma. Can J Ophthalmol. 2008;43(4):454\u201361.","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"1415_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00417-008-0944-y","volume":"247","author":"CMG Olthoff","year":"2009","unstructured":"Olthoff CMG, Hoevenaars JGMM, van den Borne BW, Webers CAB, Schouten JSAG. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2009;247(2):235\u201343.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"1415_CR39","first-page":"732","volume":"127","author":"JL Stone","year":"2009","unstructured":"Stone JL, Robin AL, Novack GD, Covert DW, Cagle GD. An objective evaluation of eyedrop instillation in patients with glaucoma. Arch Ophthalmol Chic Ill 1960. 2009;127(6):732\u20136.","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"issue":"6","key":"1415_CR40","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jfo.2016.02.004","volume":"39","author":"P Dugast","year":"2016","unstructured":"Dugast P, Thiboust P, Blumen-Ohana E, Nordmann JP. Faut-il une \u00e9ducation th\u00e9rapeutique des patients atteints de glaucome \u00e0 angle ouvert? Enqu\u00eate pr\u00e9liminaire des connaissances et de l\u2019observance aupr\u00e8s des patients. J Fr Ophtalmol. 2016;39(6):527\u201334.","journal-title":"J Fr Ophtalmol"},{"issue":"11","key":"1415_CR41","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1167\/iovs.07-0290","volume":"48","author":"DS Friedman","year":"2007","unstructured":"Friedman DS, Quigley HA, Gelb L, Tan J, Margolis J, Shah SN, et\u00a0al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007;48(11):5052\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1415_CR42","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2147\/OPTH.S475812","volume":"18","author":"K Malewicz","year":"2024","unstructured":"Malewicz K, Pender A, Chabowski M, Jankowska-Pola\u0144ska B. Impact of sociodemographic and psychological factors on adherence to glaucoma treatment\u2014A cross-sectional study. Clin Ophthalmol (Auckl NZ). 2024;18:2503\u201320.","journal-title":"Clin Ophthalmol (Auckl NZ)"},{"issue":"5","key":"1415_CR43","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10792-011-9468-2","volume":"31","author":"K Mansouri","year":"2011","unstructured":"Mansouri K, Iliev ME, Rohrer K, Shaarawy T. Compliance and knowledge about glaucoma in patients at tertiary glaucoma units. Int Ophthalmol. 2011;31(5):369\u201376.","journal-title":"Int Ophthalmol"},{"issue":"4","key":"1415_CR44","doi-asserted-by":"publisher","first-page":"630","DOI":"10.18240\/ijo.2023.04.18","volume":"16","author":"J Menino","year":"2023","unstructured":"Menino J, Camacho P, Coelho A. Initial medication adherence in newly diagnosed glaucoma patients: three adherence measures. Int J Ophthalmol. 2023;16(4):630\u20137.","journal-title":"Int J Ophthalmol"},{"key":"1415_CR45","first-page":"731","volume":"4","author":"JP Nordmann","year":"2010","unstructured":"Nordmann JP, Baudouin C, Renard JP, Denis P, Lafuma A, Laurendeau C, et\u00a0al. Measurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control: a survey. Clin Ophthalmol Auckl NZ. 2010;4:731\u20139.","journal-title":"Clin Ophthalmol Auckl NZ"},{"issue":"2","key":"1415_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ophtha.2008.09.004","volume":"116","author":"CO Okeke","year":"2009","unstructured":"Okeke CO, Quigley HA, Jampel HD, Ying G, Plyler RJ, Jiang Y, et\u00a0al. Adherence with topical glaucoma medication monitored electronically the Travatan dosing aid study. Ophthalmology. 2009;116(2):191\u20139.","journal-title":"Ophthalmology"},{"issue":"11","key":"1415_CR47","first-page":"1140","volume":"119","author":"C Wolfram","year":"2022","unstructured":"Wolfram C, Schuster AK. Glaucoma care in Germany-Results of a survey among German ophthalmologists-Part 2: treatment. Ophthalmology. 2022;119(11):1140\u20138.","journal-title":"Ophthalmology"},{"issue":"1","key":"1415_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191185","volume":"13","author":"S Frech","year":"2018","unstructured":"Frech S, Kreft D, Guthoff RF, Doblhammer G. Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients-an observational cohort study. PLoS ONE. 2018;13(1):e0191185.","journal-title":"PLoS ONE"},{"issue":"6","key":"1415_CR49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/jop.2004.20.461","volume":"20","author":"WC Stewart","year":"2004","unstructured":"Stewart WC, Konstas AGP, Pfeiffer N. Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. J Ocul Pharmacol Ther. 2004;20(6):461\u20139.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"1415_CR50","doi-asserted-by":"publisher","first-page":"348","DOI":"10.24869\/psyd.2022.348","volume":"34","author":"D Le\u0161inGa\u0107ina","year":"2022","unstructured":"Le\u0161inGa\u0107ina D, Jandrokovi\u0107 S, Mar\u010dinko D, \u0160kegro I, VidasPauk S, Tomi\u0107 M, et\u00a0al. Anxiety and treatment adherence among glaucoma patients during COVID-19 pandemic and earthquakes in Croatia. Psychiatr Danub. 2022;34(2):348\u201355.","journal-title":"Psychiatr Danub"},{"issue":"8","key":"1415_CR51","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/eye.2016.103","volume":"30","author":"AP Tse","year":"2016","unstructured":"Tse AP, Shah M, Jamal N, Shaikh A. Glaucoma treatment adherence at a United Kingdom general practice. Eye. 2016;30(8):1118\u201322.","journal-title":"Eye"},{"key":"1415_CR52","doi-asserted-by":"crossref","unstructured":"Kolko M, Hansen RF, Dal LG, Sabelstr\u00f6m E, Brandel M, Bentsen AH, et\u00a0al. Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark\u2014An observational registry study of 30 100 Danish patients with glaucoma. BMJ Open Ophthalmol [Internet]. 2024 Apr 15 [cited 2025 Nov 3];9(1). https:\/\/bmjophth.bmj.com\/content\/9\/1\/e001607.","DOI":"10.1136\/bmjophth-2023-001607"},{"issue":"1","key":"1415_CR53","doi-asserted-by":"publisher","first-page":"P71","DOI":"10.1016\/j.ophtha.2020.10.022","volume":"128","author":"SJ Gedde","year":"2021","unstructured":"Gedde SJ, Vinod K, Wright MM, et\u00a0al. Primary open-angle glaucoma preferred practice pattern. Ophthalmology. 2021;128(1):P71-150. https:\/\/doi.org\/10.1016\/j.ophtha.2020.10.022.","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01415-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01415-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01415-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:03:44Z","timestamp":1782741824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01415-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1415"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01415-z","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have completed and submitted the ICMJE disclosures form. Tom\u00e1s Hern\u00e1ndez, Sara Labay, Carlos Arciniegas, Elena \u00c1vila, Cristina Vendrell, Shirin Djavanmardi, Nuris Nuria Gabarr\u00f3, and Naiara Rela\u00f1o have no conflicts of interest to declare. Susana Duch is a consultant for Alcon, Abbvie, Bausch & Lomb, Horus Pharma, Glaukos, Th\u00e9a, and Santen. Alegria Amram declares working as a medical advisor at Horus Pharma Ib\u00e9rica at the time of publication. Elena Mill\u00e1 is a consultant for Abbvie, Santen, Salvat, AOI, Visufarma, VIU 20\/20, Thea, and Brill Pharma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study adhered to the principles of the Declaration of Helsinki and received approval from Hospital Cl\u00ednic de Barcelona Ethics Review Board (HCB\/2024\/0234). The Ethics Committee of Hospital Cl\u00ednic, both in its composition and in its procedures, complies with the standards of EMA\/CHMP\/ICH\/135\/1995 and with the current legislation that regulates its operation. The need for written informed consent was waived by the ethics review board, as no personally identifiable information was collected.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}